ARSMO Plastic Aesthetic Hospital Introduces Liquid PCL Implant GOURI in Hainan
ARSMO Plastic Aesthetic Hospital Holding Co., Ltd. has announced the inaugural application of GOURI, a...
Medical aesthetics
Jiangsu Wuzhong Pharmaceutical Partners with SPH KDL Health to Boost Aesthetics Product AestheFill
Jiangsu Wuzhong Pharmaceutical Group Corp., (SHA: 600200), a leading Chinese pharmaceutical company, has announced a...
Jiangsu Wuzhong Pharmaceutical’s Aesthetics Subsidiary Wins Approval for Facial Filler in China
Jiangsu Wuzhong Pharmaceutical Group Corp., (SHA: 600200), a prominent player in the Chinese pharmaceutical industry,...
China Medical System Holdings Secures Exclusive Rights to Promote Xihong Biopharma’s Aesthetic Fillers
China Medical System Holdings Ltd (CMS, HKG: 0867) has announced a licensing agreement with Jiangxi...
Sisram Medical’s Profhilo Accepted for Review by China’s NMPA
Sisram Medical Ltd (HKG: 1696), an Israel-based company within the Fosun Pharmaceutical Group (SHA: 600196),...
Huadong Medicine Co., Ltd Secures Partnership and Commercial Rights for Yuyan’s Botulinum Toxin
China-based Huadong Medicine Co., Ltd (SHE: 000963) has entered into an equity investment and partnership...
Sisram Medical Ltd Expands Asia-Pacific Presence with New Direct Sales Office in Japan
Sisram Medical Ltd (HKG: 1696), an Israel-based company that is part of the Fosun Pharmaceutical...
Huadong Medicine Secures Global Licensing Agreement for ATGC-110 Botulinum Toxin A Injection
China-based Huadong Medicine Co., Ltd. (SHE: 000963) has announced a strategic licensing agreement with South...
Sihuan Pharmaceutical Reports H1 2023 Revenue Dip Amid R&D Focus
Sihuan Pharmaceutical Holdings Group Ltd (HKG: 0460) has released its financial report for the first...
AbbVie’s Allergan Aesthetics Secures NMPA Approval for Juvéderm VOLUMA with Lidocaine
Allergan Aesthetics, a subsidiary of AbbVie (NYSE: ABBV), has announced that it has received marketing...
Huadong Medicine’s Subsidiary Viora Ltd’s V20 Accepted for NMPA Review
China-based Huadong Medicine Co., Ltd (SHE: 000963) has announced that the National Medical Products Administration...
Bloomage Biotech Terminates Joint Venture with Medytox Inc. for Botulinum Toxin Development
China-based Bloomage Biotech (SHA: 688363) has revealed that a termination agreement has been signed with...
Sisram Medical’s Alma Veil Launches in the US for Vascular Lesion Treatment
Alma Lasers, a subsidiary of Sisram Medical (HKG: 1696), has announced the commercial availability of...
Shanghai Fosun Pharmaceutical Submits Daxibotulinumtoxin A (RT002) for NMPA Approval
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196), a China-based pharmaceutical company, has announced a...
Sisram Medical’s Alma Lasers Acquires PhotonMed International Ltd, Expanding Global Presence
Sisram Medical Ltd (HKG: 1696), an Israel-based company and part of the Fosun Pharmaceutical Group...
Fosun Pharmaceutical’s Sisram Opens Wellness Center in Chicago for Beauty and Health
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196, HKG: 2196) has announced the establishment of...
Samyang Holdings Partners with Yxintent for Lafullen Dermal Filler in China
South Korea-based Samyang Holdings Biopharm Group has secured a partnership with Hangzhou-based Yxintent, a specialist...
China’s Regulatory Bodies Unveil Guidelines to Strengthen Supervision of Medical Aesthetic Industry
The State Administration for Market Regulation, National Health Commission, National Administration of Traditional Chinese Medicine,...
Huadong Medicine Reports 9.12% YOY Revenue Growth and 13.24% Increase in Net Profits for 2022
Huadong Medicine Co., Ltd (SHE: 000963), a leading China-based pharmaceutical company, has released its 2022...
Shanghai Fosun Pharmaceutical Submits Market Approval Filing for Daxibotulinumtoxin A in China
Shanghai Fosun Pharmaceutical (Group) Co., Ltd (SHA: 600196) has announced a market approval filing to...